GAMMA Investing’s Precision BioSciences DTIL Stock Holding History

GAMMA Investing’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.63K	Buy	+260	New	+$1.96K	﹤0.01%	3993

Other funds holding DTIL

Beacon Financial Strategies Raleigh, North Carolina $203M AUM 12.07% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

GAMMA Investing's DTIL Position: Q3 2026 in Review

GAMMA Investing opened a new position in Precision BioSciences (DTIL) in Q3 2026: 260 shares worth $1.63K. The stake represents ﹤0.01% of the portfolio and ranks #3993 among its holdings.

10 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

GAMMA Investing held 260 shares of Precision BioSciences worth $1.63K as of Q3 2026.
Precision BioSciences was a new GAMMA Investing position in Q3 2026.
Precision BioSciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3993 holding.
10 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.